GE HealthCare Technologies Inc. (GEHC)
GEHC Stock Rises as FDA Clears MIM Software's Centiloid Tool
GE Healthcare's MIM Software announces the receipt of FDA clearance for its Centiloid scaling tool to perform PET-based amyloid imaging.
GE HealthCare: The Image Of More Upside Is Very Real
GE HealthCare Technologies has shown promising performance, with a 12% stock increase since June, outperforming the S&P 500's 2.9% rise. Despite some revenue declines in key segments, the PDx segment's 12.5% growth and overall profitability improvements are encouraging. Management's revised guidance suggests a positive outlook, with expected EPS growth and improved EBIT margins, indicating strong future potential.
This GE HealthCare Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
GE HealthCare Stock Is Rising. Why One Analyst Says Buy.
BTIG analyst Ryan Zimmerman upgraded GE HealthCare stock to Buy from Hold. His new price target is $100, implying about 15% upside.
GE HealthCare's stock pulls back after former parent sells off half its stake
GE HealthCare's stock is ending a good week on a bad note on Friday, after its former parent, now known as GE Aerospace, took advantage of the recent rally to sell off about one half of its remaining stake.
GE Healthcare (GEHC) stock is a bargain – Morningstar
GE Healthcare (NASDAQ: GEHC) stock price has bounced back in the past few months, helped by the overall recovery of American equities and the view that it is a bargain company. It rose to a high of $88.51 on Thursday, its highest level since April 29th.
GE Healthcare to Unveil AI-Driven Cardiac Diagnostics at ESC 2024
GEHC launches AI-enhanced ultrasound and ECG-less Cardiac CT technologies, offering rapid, accurate cardiac diagnostics at the point of care.
GE HealthCare's (GEHC) Tie-Up to Boost Female Pelvic Healthcare
GE HealthCare's (GEHC) latest collaboration is likely to equip clinicians with a toolset to deliver enhanced care to female patients and improve the patient experience.
GE HealthCare Q2 Earnings Recap (Rating Downgrade)
GE HealthCare's Q2 earnings were disappointing, with revenue stagnating and cost efficiencies driving earnings, leading to a lowered price target and sell rating. The company continues to lag behind the market in various healthcare sectors, with AI potential diminishing and a decreased focus on R&D. Upside potential lies in the healthcare market and AI technology, but GEHC's slow progress and competition pose challenges for future growth.
Why GE HealthCare Technologies (GEHC) is a Top Value Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
GE HealthCare (GEHC) Q2 Earnings Beat Estimates, Net Margin Up
GE HealthCare's (GEHC) second-quarter results witness declining segmental revenues in imaging, ultrasound and patient care. The bottom line improves on better pricing.
GE HealthCare Stock Surges as Profits Beat Estimates, Despite China Sales Headwinds
GE HealthCare (GEHC) shares rose over 4% in early trading Wednesday after the company reported second-quarter profits that beat analysts' estimates.
